Discover how phospholipids and molecular subclasses are transforming ovarian cancer detection through metabolomics and advanced biomarker analysis.
Discover how researchers are targeting the tumor microenvironment to develop innovative treatments for ovarian cancer, focusing on NNMT inhibitors and combination therapies.
Exploring how Patient-Derived Xenograft (PDX) models are revolutionizing our understanding of ovarian cancer chemoresistance and enabling new treatment approaches.